Source: https://www.immunetolerance.org/professionals/research/publications?keys=&field_pub_year_value=&field_pub_category_target_id=All&type_1=All&page=5
Timestamp: 2019-04-23 15:57:28+00:00

Document:
Carreno M, Ciancio G, Burke GW, Cirocco R, Mathew J, Miller J, Esquenazi V, Gomez C, Salma F, Jin Y (2006). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs thym. ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006.
Boyce K, Spencer T (2006). Using automated extract, transform and load (ETL) processes to build an integrated warehouse of clinical and mechanistic results. American Medical Informatics Association Symposium Spring Congress, Phoenix, AZ, May, 2006.
Cirocco R, Carreno M, Mathew J, Vallone T, Rosen A, Burke GW, Ciancio G, Esquenazi V, Miller J, Kleiner G (2006). Upregulation of FOXP3 in renal transplantation after antibody induction regimens with and without bone marrow or stem cells. World Transplant Congress, Boston, MA, July 22-27, 2006.
Francis JN, Wilcock LK, Paraskavopoulos G, Till SJ, Durham SR (2006). Time-course analysis of a Double-Blind Placebo Controlled Trail of Grass Pollen Immunotherapy: increased cellular IL-10 . Collegium Internationale Allergologicum, Malta, May 5-10, 2006.
Hernandez-Fuentes MP, Sagoo P, Flavia R, Jimenez E, Perucha E, Le Moine A, Craciun L, Peters B, Braudeau C, Brouard S, Chapman S, Warrens A, Goldman M, Soulillou JP, Janssen U, Wood K, Lechler RI, Sawitszki B, Trzonkowski P, Warnecke G, Libin M, Volk H-D (2006). Indices of tolerance: Interim Report. (Abstract #999) World Transplant Congress, Boston, MA, July 22-27, 2006.
Kawai T, Spitzer T, Tolkoff-Rubin N, Saidman S, Dey B, Goes N, Ko D, Hertl M, Cotter P, Wong W, Colvin R, Sykes M, Cosimi AB, Sachs D, WilliamsW (2006). Successful Induction of Renal Allograft Tolerance in HLA-Mismatched Kidney Transplant Recipients. FASEB Summer Research Conference, Snowmass, CO, June 3-8, 2006.
Klunker S, Francis JN, Casale TB, Durham SR (2006). Anti-IgE Therapy Inhibits IgE-facilitated Allergen Presentation and Increases the Efficacy of Ragweed Immunotherapy. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Knechtle SJ, Sollinger HW, Jankowska-Gan E, Burlingham WJ, Bloom DJ (2006). Preliminary results of a tolerance trial in renal transplantation. World Transplant Congress, Boston, MA, July 22-27, 2006.
Mathew J, Carreno M, Cirocco R, Rosen A, Vallone T, Garcia-Morales R, Burke GW, Ciancio G, Esquenazi V, Miller J (2006). Circulating and graft infiltrating regulatory cells in donor stem cell infused kidney transplant patients treated with alemtuzumab. 12th Innovative Therapeutics in Transplantation Meeting, Nantes, France, June 15, 2006.
Mathew J, Cirocco R, Rosen A, Vallone T, Gomez C, Blomberg B, Fuller L, Burke GW, Ciancio G, Esquenazi V, Miller J (2006). Tolerogenicity of graft infiltrating lymphocytes in donor stem cell infused kidney transplant recipients treated with ale. ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006.
Mathew J, Vallone T, Carreno M, Garcia-Morales R, Rosen A, Gomez C, Burke GW, Ciancio G, Esquenazi V, Miller J, Blomberg B, Fuller L (2006). Regulatory cells of donor and recipient phenotypes in donor stem cell infused kidney transplant recipients treated with a. World Transplant Congress, Boston, MA, July 22-27, 2006.
Parrish D, McCafferty K (2006). A web-based clinical trials management system: Integration, annotation and delivery of bioinformatics and clinical data w. American Medical Informatics Association Spring Congress, Phoenix, AZ, May, 2006.
Raddassi K, Bourcier K, Estevam J, Gisler T, Hafler DA, Seyfert-Margolis V (2006). Comparison of two methods CPT and Ficoll to isolate mononuclear cells from peripheral blood. Effect on viability and fu. FOCIS Annual Meeting, San Francisco, CA, June 1-5, 2006.
Sagoo P, Hernandez-Fuentes M, Jimenez-Vera E, Rovis F, Hilton R, Warrens A, Lechler RI (2006). Fingerprinting tolerance in Renal Transplantation. (Abstract #A21) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.
Sagoo P, Hernandez-Fuentes MP, Jimenez E, Perucha E, Warrens A, Lechler RI, Flavia R, Stevenson S, Milton R (2006). Advances in Immune Monitoring in Renal Transplantation. (Abstract #1888) World Transplant Congress, Boston, MA, July 22-27, 2006.
Shamji MH, Wilcock LK, Larché M, Francis JN, Durham SR (2006). Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Effica. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Stevenson S, Hernandez-Fuentes M, Lechler RI, Jiang S, Lombardi G, Barber L (2006). Efficacy of Indirect pathway antigen processing and allorecognition. (Abstract #918) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.
Vandenbark AA (2006). Treatment of MS patients with TCR peptide vaccine. 4th International Workshop on T-Cell Vaccination, Galillee, Israel, February, 2006.
Wilcock LK, Francis JN, Till SJ, Durham SR, Paraskavopoulos G (2006). Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immuno. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Wilcock LK, Francis JN, Aalberse RC, Till SJ, Durham SR, Paraskevopolous G, Stapel SO (2006). Increased serum inhibitory activity for basophil histamine release corresponds with reductions in early skin responses i. British Society of Allergy and Clinical Immunology, Loughborough, UK, July, 2006.
Martins SB, Parrish D, Das AK, Shankar R, O’Connor MJ (2006). Towards semantic interoperability in a clinical trials management system. Fifth International Seman-tic Web Conference (ISWC 2006), Athens, GA, Nov 5-9, 2006.
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2006). A Knowledge-Based System for Managing Clinical Trials. 19th IEEE International Symposium on Computer-Based Medical Systems, Salt Lake City, Utah, June 22-23, 2006.
Shankar RD, O'Connor MJ, Parrish DB, Martins SB, Das AK (2006). Epoch: an Ontological Framework to Support Clinical Trials Management. International Workshop on Health Information and Knowledge Management (HIKM 2006), Arlington, VA, Nov 11, 2006.
Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL.
Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL. (2005). Comparison of RNA Preparation Methods and Their Effect on Cytokine/Chemokine Gene Expression. (Abstract #Su1.60) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V.
Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V. (2005). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs Thymoglobulin. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V.
Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V. (2005). Careno-T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipien. American Transplant Congress, Seattle, WA, May 21, 2005.
Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG.
Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG. (2005). Casale-Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT). (Abstract #259) AAAAI Annual Meeting, San Antonio, TX, March 18-22, 2005.
Cirocco R, Mathew J, Esquenazi V, Miller J., Careno M, Valone T (2005). Cirocco-Increased production of the regulatory T-cell transcription factor Fox P-3m-RNA and CD4+CD25+ cells in Campath-1H and do. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Asare AL, Kolchinsky SA, Seyfert-Margolis VL., Collin F, Speed TP (2005). Collin-NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation. (Abstract #Su2.110) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J.
Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J. (2005). Garcia-Comparative chimerism levels in cadaver and living related donor whole bone marrow infused kidney recipients vs. a 2X ste. th Basic Science Symposium of the International Transplantation Society, La Baule, France, June 19-23, 2005.
Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R.
Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R. (2005). Hernandez0Immune Monitoring in Renal Transplantation. British Society of Immunology, Harrogate, UK, December, 2005.
Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B.
Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B. (2005). Kawai. (Abstract #1535) American Transplant Congress, Seattle, WA, May 21, 2005.
Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K.
Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K. (2005). Khoury-A Phase I Trial of CTLA4Ig Treatment in MS. (Abstract #S46.004) 57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL, April 9-15, 2005.
Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG.
Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG. (2005). Kline-Omalizumab Plus Rush Immunotherapy (RIT) Is More Effective Than RIT Alone In Preventing Ragweed-Induced Seasonal Allergic . (Abstract #827) 61st Annual Meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, TX, March 18-22, 2005.
Klunker S, Francis JN, Durham SR (2005). Klunker-Ragweed immunotherapy serum inhibits facilitated allergen presentation. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.
Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA.
Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA. (2005). Liu-Immune monitoring: the effects of hOKT3γ1 (Ala-Ala) in a patient with new onset type 1 diabetes mellitus. (Abstract #Su1.70) Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Vallone T, Carreno M, Rosen A, Gomez C, Garcia-Morales R, Blomberg B, Fuller L, Ciancio G, Esquenazi V, Miller J, Mathew JM, Burke G (2005). Mathew-Regulatory cell development in an LRD-kidney transplant recipient treated with alemtuzumab and donor stem cell infusions . ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A.
Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A. (2005). Offner-Expression of the Treg cell associated Foxp3 gene is decreased in MS patients and increases following immunization with a. 5th Meeting of the European Neurological Society, Vienna, Austria, June 18-22, 2005.
Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR.
Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR. (2005). Paraskevop-Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses. J Allergy Clin Immunology, 115, S266, 2005.
Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V.
Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V. (2005). Raddassi-Effect of freezing/thawing conditions and their optimization for quality control of PBMC viability and functional assay. (Abstract #Su1.106) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Larché M, Shamji M, Wilcock L, Durham S, Francis J.
Larché M, Shamji M, Wilcock L, Durham S, Francis J. (2005). Shamji-Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monito. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.
Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A.
Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A. (2005). Shamkar-A knowledge-driven approach to manage clinical trial protocols in the Immune Tolerance Network. American Medical Informatics Association Symposium, Unknown, October 25, 2005.
Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D.
Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D. (2005). Vandenbark-Decreased Foxp3 levels in MS patients are normalized by TCR peptide vaccination. 19th National Congress of the Polish Neurological Society, Lodz, Poland, Aug 31-Sept 3, 2005.
Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D.
Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D. (2005). Vandenbark-TCR peptide vaccination in MS induces high levels of IL-10 and restores decreased Foxp3 levels. ECTRIMS/ACTRIMS, Thessaloniki, Greece, Sept 28-Oct 1, 2005.
Wilcock LK, Wachholz PA, Klunker S, Francis JN, Durham SR, Na D H, Larsen JN (2005). Wilcock0Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT). J Allergy Clin Immunology, 115, S265, 2005.
Dosch HM, Seyfert V, Greenbaum CJ, Gitelman SE, Palmer JP, Brooks-Worrell BM, Herold K (2004). BrooksWorrell-Marked Differences in T Cell Reactivity in Recently Diagnosed Type 1 Diabetes Patients Versus Controls. (Abstract #2778) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Casale TB (2004). Casale-Anti-IgE monoclonal antibody administered with immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.
Casale TB (2004). Casale-Omalizumab And Immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.
Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.
Eisenbarthh GS (2004). Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.. XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M (2004). Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. (Abstract #P931) International Congress of Transplantation, Vienna, Austria, Sept 5-10, 2004.

References: V.

 V. 
 V.

 V. 
 V.

 V.